我们收到并阅读了上海证券交易所向贵公司出具的"关于对上海家化联合 股份有限公司 2024 年年度报告的信息披露监管问询函"(以下简称"问询函"), 我们仅以上述我们对 2020 年度财务报表、2021 年度财务报表、2022 年度 财务报表、2023 年度财务报表、2024 年度财务报表和 2024 年度内部控制 所执行的审计工作为依据,对贵公司就问询函中需要审计师发表意见的问题 的回复提出我们的说明。详见附件。 本说明仅供上海家化用于回复问询函中的问题时参考,不得用作其他用 途或向除上海证券交易所以外的其他第三方提供。 普华永道 上海家化联合股份有限公司董事会: 普华永道中天会计师事务所(特殊普通合伙)(以下简称"我们"或"普华永 道")接受上海家化联合股份有限公司(以下简称"上海家化"或"贵公司")委托, 审计了上海家化 2020年 12月 31日、2021年 12月 31日、2022年 12月 31 日、2023年 12 月 31 日和 2024 年 12 月 31 日的合并及公司资产负债表、 2020 年度、2021 年度、2022年度、2023年度和 2024 年度合并及公司利 润表、合并及公司股东 ...

Core Viewpoint - Procter & Gamble (P&G) announced plans to cut approximately 7,000 non-production jobs globally over the next two years, representing 15% of such positions, as part of a restructuring effort to address performance challenges [1][13] Group 1: Talent Loss - P&G has experienced a significant outflow of high-level management talent in China over the past decade, with several core executives leaving the company [1][5] - Notable departures include former sales presidents and high-ranking executives who have moved to competitors or other industries, indicating a trend of talent migration from P&G [2][4] - The phenomenon of "P&G alumni" is prevalent, with many former executives taking on prominent roles in various sectors, including e-commerce and new consumer brands [6][5] Group 2: Market Position and Strategy - P&G's revenue growth in China has slowed significantly, with traditional product categories facing increased competition and rising costs, diminishing the company's attractiveness to talent [7][9] - The company's global strategic adjustments have not aligned well with local market changes, leading to a perception of limited decision-making autonomy for local executives [9][11] - P&G's conservative talent incentive mechanisms have become less competitive compared to local companies, which offer more attractive compensation packages and growth opportunities [11][12] Group 3: Organizational Culture - P&G's traditional organizational culture, characterized by meticulous planning and a slower pace of innovation, contrasts sharply with the fast-paced, iterative culture of the internet and new consumer sectors [12][13] - The company's rigid structure may hinder its ability to adapt quickly to market changes, prompting former employees to seek more dynamic environments [12][13] Group 4: Future Outlook - P&G's drastic restructuring efforts, including significant layoffs and brand portfolio reductions, reflect the company's struggle to maintain its market position in an evolving consumer landscape [1][13] - The shift towards digital and niche brands has challenged P&G's historical dominance, as smaller, agile companies leverage e-commerce and social media to connect with younger consumers [13]

Core Viewpoint - The company, Two-faced Needle, faces scrutiny from the stock exchange after disclosing its 2024 annual report, highlighting issues such as "non-urgent borrowing" and weak profitability in its main business [1] Financial Performance - As of the end of 2024, Two-faced Needle reported short-term borrowings of 90 million yuan, a significant increase of 55.17% year-on-year, despite holding a large amount of cash totaling 1.273 billion yuan, which accounts for 46.78% of total assets [2] - The company has a unique arbitrage model, with an average annual deposit interest rate of 3.26%, while the actual financing cost of loans obtained through various policies is as low as 0.22%-2.6%, resulting in a spread of 3.04 percentage points [2] - Interest income reached 40.72 million yuan in 2024, constituting 455% of the net profit excluding non-recurring items, indicating a heavy reliance on financial operations rather than core business activities [3] Business Challenges - The company derives 70% of its revenue from hotel daily necessities but faces structural challenges, including weak bargaining power as a supplier, low-value-added products, and a lag in channel transformation [4] - The reliance on external products accounts for 30% of its offerings, further compressing profit margins, while R&D investment remains below 1%, significantly lower than industry leaders [4] - Despite a strategic focus on "focusing on the main business and deepening the integration of medical and elderly care," the company has seen limited success in cost reduction and efficiency improvement, with sales expenses increasing by only 6.99% and management expenses rising by 15.33% in 2024 [4]

美容护理行业资金流向排名 | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 002094 | 青岛金王 | -6.29 | 25.12 | -20910.28 | | 300886 | 华业香料 | -2.63 | 39.78 | -3835.15 | | 300132 | 青松股份 | -1.60 | 10.12 | -3010.38 | | 600249 | 两面针 | -3.41 | 6.36 | -2991.43 | | 600315 | 上海家化 | -3.90 | 1.46 | -2132.01 | | 301108 | 洁雅股份 | -5.88 | 11.90 | -1966.24 | | 301009 | 可靠股份 | -2.72 | 11.97 | -1919.71 | | 301371 | 敷尔佳 | -1.70 | 4.92 | -1066.61 | | 603605 | 珀莱雅 | -0.32 | 1.30 | -1002.44 | | 605009 | 豪悦护理 | -1. ...

Core Viewpoint - The beauty industry is experiencing a surge in interest in PDRN (Polydeoxyribonucleotide), with numerous domestic and international brands launching products featuring this ingredient, indicating a promising market outlook for PDRN in the coming years [2][3][5]. Group 1: Market Trends and Growth - The global PDRN market was approximately 180 million yuan in 2023 and is expected to reach 3 billion yuan by 2030, with a compound annual growth rate (CAGR) of 43% from 2024 to 2030 [2]. - Currently, there are 3,894 brands using PDRN, with 16,901 products containing this ingredient, showing rapid growth in the market [5]. - The PDRN market is characterized by a diverse range of players, including domestic brands like Zhanmei Ya and international giants like L'Oréal and Amorepacific, all actively entering the PDRN space [2][6][13]. Group 2: Product Innovations and Technologies - Zhanmei Ya's "Ball PDRN Energy Stick" achieved over 10 million in sales within a month of launch, highlighting the strong consumer demand for PDRN products [7]. - Various brands are employing innovative technologies to enhance PDRN's effectiveness, such as microencapsulation and lactobacillus vesicle technology, to improve skin absorption [29][30]. - PDRN is being integrated into a wide range of products, including serums and creams, with brands like CNP and Lancôme emphasizing its clinical-grade efficacy [9][11][30]. Group 3: Scientific Basis and Mechanisms - PDRN has a long history of use in the beauty industry, with established benefits in skin repair and regeneration, supported by over 600 research publications [14][23]. - The mechanism of PDRN involves promoting cell proliferation and regulating inflammatory responses, making it a valuable ingredient for anti-aging and skin repair [23][24]. - PDRN's unique properties, such as its non-antigenic nature and low toxicity, contribute to its safety and effectiveness in cosmetic applications [21][23]. Group 4: Challenges and Future Prospects - Despite its popularity, PDRN faces challenges related to its large molecular size and poor transdermal absorption, which are critical for its effectiveness in topical applications [29][30]. - The market is witnessing a trend towards artificial synthesis of PDRN, which could enhance production consistency and reduce costs, making it more accessible [39][41]. - As the market matures, there is a need for better consumer education regarding PDRN's benefits and limitations to avoid misconceptions about its efficacy [33][35].

Market Overview - A-shares opened higher on June 11, with the Shanghai Composite Index surpassing 3400 points during the midday session, ultimately closing up by 0.52% at 3402.32 points [1] - The Shenzhen Component Index rose by 0.83% to 10246.02 points, while the ChiNext Index increased by 1.21% to 2061.87 points [1] - Total trading volume in the Shanghai and Shenzhen markets was 12,555 billion, a decrease of 1,598 billion from the previous trading day [1] Sector Performance - The financial sector led the gains, with significant activity in rare earth permanent magnets, short drama games, automotive parts, solid-state batteries, and digital currency themes [1] - The rare earth sector continued to strengthen, with several stocks hitting the daily limit or rising over 10% [3] - Automotive stocks showed strong performance throughout the day, with multiple stocks also hitting the daily limit or rising over 10% [3] - The pharmaceutical sector experienced a downturn, with several stocks declining over 6% [3] - Communication stocks faced notable declines, with several companies dropping over 5% [3] Investor Sentiment and Market Outlook - Citic Securities noted that investor sentiment in May was generally stable, with expectations of continued market risk appetite due to improved US-China trade relations [5] - Zhongyuan Securities indicated that the market's liquidity remains ample following recent monetary policy adjustments, with expectations for further policy support [6] - Dongguan Securities highlighted the potential for structural opportunities in the market driven by positive economic indicators and technological breakthroughs [7] - Shenwan Hongyuan suggested that the market may remain in a consolidation phase, with a focus on key economic data and policy developments in June [8]

Group 1 - The sanitary napkin industry faces a trust crisis after issues were exposed on CCTV's 315 Gala, leading to Huang Zitao's rapid development and launch of the Duowei brand, achieving sales of 40 million in its first live stream, priced at less than 60% of traditional brands [2] - The beauty industry remains strong, with Proya surpassing Shanghai Jahwa with a revenue of 10.778 billion, marking a significant shift as the top ten companies now require a minimum revenue of 2.569 billion, and R&D investments have surged, with companies like Shiseido and Giant Bio seeing over 40% growth in R&D spending [2] - The cruise industry is attempting to recover from a price collapse in the summer of 2024, with some routes seeing price drops of 60%, leading companies like Royal Caribbean and Aida Cruises to introduce cultural crossover themes to attract customers, resulting in a record of 30,000 people entering and exiting Shanghai Port in a single day during the May Day holiday [2] Group 2 - The value of intellectual property (IP) is being reaffirmed, as Light Media's "Nezha: The Devil's Child" grossed 15 billion at the box office, with a net profit increase of 374.79% to 2.016 billion in the first quarter, despite concerns over the film industry's reliance on single IPs [3] - Consumer-facing IP commercialization is booming, with brands like Liangpinpuzi and Qiaqia collaborating over 50 times, generating 7.1 billion in revenue; the Palace Museum's dining experience has become a trend with an average spending of 500 per person, showcasing the overwhelming success of cultural IP in driving consumer behavior [3] - The traditional employment relationship is evolving, as seen in the live stream featuring Dong Mingzhu and Meng Yutong, highlighting a shift from loyalty to a more flexible employment approach among younger generations [3]

A股美容护理板块午后再度拉升，洁雅股份涨超15%，华业香料此前涨停，水羊股份涨超8%，青松股 份、拉芳家化、上海家化、科思股份、贝泰妮等跟涨。 订阅A股市场资讯 +订阅 ...

"聪明钱"流向曝光！暗盘资金破解主力操盘密码>> 美容护理板块走高，华业香料（300886）涨停，水羊股份（300740）、洁雅股份（301108）涨超10%， 青松股份（300132）、拉芳家化（603630）、上海家化（600315）、科思股份（300856）、贝泰妮 （300957）等跟涨。 ...

Group 1 - The beauty and personal care sector has shown strong performance in Q1 2025, with the SW Beauty Care Index rising by 13.4%, leading all 31 SW primary industries [4][10][12] - The cosmetics segment is focusing on enhancing brand matrices and introducing new ingredients, benefiting from an optimized competitive landscape [4][6] - The medical beauty market is evolving with new products stimulating consumer interest, and domestic companies are expected to become major competitors in the light medical beauty sector [4][6] Group 2 - The e-commerce sector is witnessing new consumption models and brands, which are helping to drive growth in the industry [4][6] - The report recommends several companies in the cosmetics sector, including Up Beauty and Proya, which have low PE multiples and strong growth potential [4][6] - In the medical beauty segment, companies with high R&D barriers and strong profitability, such as Aimeike, are highlighted as key investment opportunities [4][6] Group 3 - The personal care market is projected to reach CNY 283.3 billion by 2024, with a compound annual growth rate (CAGR) of 8.4% from 2023 to 2028 [32][34] - Domestic brands are increasingly replacing foreign brands in the personal care sector, with a notable rise in innovative products and marketing strategies [32][36] - The high-end market is experiencing significant growth, with premium products seeing a 27% increase in average transaction value in H2 2024 [44]